Prolia (denosumab) - Amgen
Bimzelx (bimekizumab) - UCB
ANV419 - Anaveon
Actemra IV (tocilizumab) - Roche, JW Pharma
http://www.ncbi.nlm.nih.gov/pubmed/39125732
 
Ahmad Dawalibi; Amal Ahmed Alosaimi; Khalid S Mohammad
 
Aug 11, 2024
 
Prev Next